1,3-Bis(2,4,6-trimethylphenyl)imidazolinium Chloride>98.0%(HPLC)(T)5g

3-Bromo-5-nitroindazole, 98%, 5g

DMTr-LNA-5MeU-3-CED-phosphoramidite, 250mg

1,10-Diiododecane, 95.0%, 5g

2-Methoxymethoxy-4-(trifluoromethyl)phenylboronic acid, 98%, 250mg

2,3,5,6-Tetrahydroxycyclohexa-2,5-diene-1,4-dione hydrate, 95.0%, 5g

spiro[indole-3,3'-piperidin]-2(1H)-one hydrochloride, 95.0%, 250mg

2,3-Difluoro-1-methoxy-4-(methylsulfanyl)benzene, 98%, 1g

(3-Chloro-5-fluoro-4-hydroxyphenyl)boronic acid, 95.0%, 100mg

GC-Kapillarsäule ROTI®Cap-5, unpolar, L 25 m, Ø-Innen 0,20 mm, Filmd. 0,20 µm, 1 Stück

N-(tert-Butyl)acrylamide, 98.0%, 500g

5-Fluoro-2,4-dimethoxyaniline, 95.0%, 25g

1-Methyl-6-oxo-1,6-dihydro-pyridazine-3-carboxylic acid, 95.0%, 100mg